Ameliora Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Ameliora Wealth Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$163K	Sell	325 -633	-66%	-$304K	0.05%	114
2026 Q1	$471K	Sell	958 -72	-7%	-$39.1K	0.15%	72
2025 Q4	$597K	Buy	1,030 +380	+58%	+$215K	0.18%	62
2025 Q3	$315K	Buy	650 +92	+16%	+$42.8K	0.11%	88
2025 Q2	$226K	Hold	558	–	–	0.08%	95
2025 Q1	$278K	Buy	558 +34	+6%	+$18.4K	0.1%	85
2024 Q4	$273K	Sell	524 -60	-10%	-$33K	0.1%	86
2024 Q3	$361K	Buy	584 +51	+10%	+$30.2K	0.15%	63
2024 Q2	$295K	Hold	533	–	–	0.13%	70
2024 Q1	$310K	Hold	533	–	–	0.14%	72
2023 Q4	$283K	Sell	533 -166	-24%	-$80.3K	0.14%	70
2023 Q3	$354K	Hold	699	–	–	0.21%	60
2023 Q2	$365K	Sell	699 -639	-48%	-$345K	0.23%	63
2023 Q1	$771K	Buy	+1,338	New	+$754K	0.45%	50

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Ameliora Wealth Management's TMO Position: Q2 2026 in Review

Ameliora Wealth Management reduced its Thermo Fisher Scientific (TMO) stake by 66% in Q2 2026, selling an estimated $304K and leaving 325 shares worth $163K. The position accounts for 0.05% of the portfolio, ranked #114.

Ameliora Wealth Management first reported a position in TMO in Q1 2023 and has held it in 14 quarters since. The position peaked at $771K in Q1 2023. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Ameliora Wealth Management held 325 shares of Thermo Fisher Scientific worth $163K as of Q2 2026.
Ameliora Wealth Management sold 633 Thermo Fisher Scientific shares in Q2 2026, an estimated $304K.
Thermo Fisher Scientific made up 0.05% of Ameliora Wealth Management's portfolio in Q2 2026, its #114 holding.
Ameliora Wealth Management first reported a position in Thermo Fisher Scientific in Q1 2023 and has held it in 14 quarters since.
Ameliora Wealth Management's Thermo Fisher Scientific position peaked at $771K in Q1 2023.
2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Ameliora Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.